RNU6-1291P

Across TCGA pan-cancer cohorts, RNU6-1291P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU6-1291P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RNU6-1291P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1291P expression acts as an unfavorable survival marker, although some lineages such as CESC and ESCA show a favorable association.

OV, BLCA, and DLBC are the cancer types where RNU6-1291P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	II,III,IV	0.408	0.692	.031	54	view →
BLCA	OS	Tertile	IV	0.082	0.575	.011	36	view →
DLBC	DFS	Tertile	II,III,IV	0.022	0.837	<.001	36	view →
LUAD	OS	Tertile	All	0.256	0.697	.024	18	view →
KIRP	OS	Tertile	II,III,IV	0.199	0.771	.030	12	view →
TGCT	DFS	Tertile	All	0.168	0.688	.011	6	view →
CESC	DFS	Tertile	II,III,IV	1.000	0.758	.035	6	view →
ESCA	DFS	Tertile	All	1.000	0.603	.042	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU6-1291P–OV (OS)

Open the OV breakdown →